Other findings support a potential role of RASSF1C as oncogene, promoting beta-catenin (CTNNB1) accumulation in HeLa cells [36] and proliferation of lung cancer cells [37], supporting cell migration and attenuated apoptosis in breast cancer [38]. Here, CTNNB1 is linked to breast carcinoma.